Search filters

List of works by Jan Dürig

Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

scientific article published on 20 July 2020

Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma

scientific article published on 27 August 2019

Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.

scientific article

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma

scientific article published on 07 January 2021

Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis

scientific article published on 09 April 2018

Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia

scientific article published on 21 January 2014

Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial

scientific article published on 07 February 2020

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

scientific article published in 2022

Paulina is supported by:

About Paulina

Help